검색결과 : 10건
| No. | Article |
|---|---|
| 1 |
Mutation alters injury response to drive cancer Vassiliadis D, Dawson MA Nature, 590(7847), 557, 2021 |
| 2 |
Mutation alters injury response to drive cancer Vassiliadis D, Dawson MA Nature, 590(7847), 2021 |
| 3 |
HBO1 is required for the maintenance of leukaemia stem cells MacPherson L, Anokye J, Yeung MM, Lam EYN, Chan YC, Weng CF, Yeh P, Knezevic K, Butler MS, Hoegl A, Chan KL, Burr ML, Gearing LJ, Willson T, Liu J, Choi J, Yang YQ, Bilardi RA, Falk H, Nguyen N, Stupple PA, Peat TS, Zhang M, De Silva M, Carrasco-Pozo C, Avery VM, Khoo S, Dolezal O, Dennis ML, Nuttall S, Surjadi R, Newman J, Ren B, Leaver DJ, Sun YX, Baell JB, Dovey O, Vassiliou GS, Grebien F, Dawson SJ, Street IP, Monahan BJ, Burns CJ, Choudhary C, Blewitt ME, Voss AK, Thomas T, Dawson MA Nature, 577(7789), 266, 2020 |
| 4 |
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation Gilan O, Rioja I, Knezevic K, Bell MJ, Yeung MM, Harker NR, Lam EYN, Chung CW, Bamborough P, Petretich M, Urh M, Atkinson SJ, Bassil AK, Roberts EJ, Vassiliadis D, Burr ML, Preston AGS, Wellaway C, Werner T, Gray JR, Michon AM, Gobbetti T, Kumar V, Soden PE, Haynes A, Vappiani J, Tough DF, Taylor S, Dawson SJ, Bantscheff M, Lindon M, Drewes G, Demont EH, Daniels DL, Grandi P, Prinjha RK, Dawson MA Science, 368(6489), 387, 2020 |
| 5 |
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity Burr ML, Sparbier CE, Chan YC, Williamson JC, Woods K, Beavis PA, Lam EYN, Henderson MA, Bell CC, Stolzenburg S, Gilan O, Bloor S, Noori T, Morgens DW, Bassik MC, Neeson PJ, Behren A, Darcy PK, Dawson SJ, Voskoboinik I, Trapani JA, Cebon J, Lehner PJ, Dawson MA Nature, 549(7670), 101, 2017 |
| 6 |
The cancer epigenome: Concepts, challenges, and therapeutic opportunities Dawson MA Science, 355(6330), -, 2017 |
| 7 |
Click chemistry enables preclinical evaluation of targeted epigenetic therapies Tyler DS, Vappiani J, Caneque T, Lam EYN, Ward A, Gilan O, Chan YC, Hienzsch A, Rutkowska A, Werner T, Wagner AJ, Lugo D, Gregory R, Molina CR, Garton N, Wellaway CR, Jackson S, MacPherson L, Figueiredo M, Stolzenburg S, Bell CC, House C, Dawson SJ, Hawkins ED, Drewes G, Prinjha RK, Rodriguez R, Grandi P, Dawson MA Science, 356(6345), 1397, 2017 |
| 8 |
BET inhibitor resistance emerges from leukaemia stem cells Fong CY, Gilan O, Lam EYN, Rubin AF, Ftouni S, Tyler D, Stanley K, Sinha D, Yeh P, Morison J, Giotopoulos G, Lugo D, Jeffrey P, Lee SCW, Carpenter C, Gregory R, Ramsay RG, Lane SW, Abdel-Wahab O, Kouzarides T, Johnstone RW, Dawson SJ, Huntly BJP, Prinjha RK, Papenfuss AT, Dawson MA Nature, 525(7570), 538, 2015 |
| 9 |
Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells Tchasovnikarova IA, Timms RT, Matheson NJ, Wals K, Antrobus R, Gottgens B, Dougan G, Dawson MA, Lehner PJ Science, 348(6242), 1481, 2015 |
| 10 |
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, Robson SC, Chung CW, Hopf C, Savitski MM, Huthmacher C, Gudgin E, Lugo D, Beinke S, Chapman TD, Roberts EJ, Soden PE, Auger KR, Mirguet O, Doehner K, Delwel R, Burnett AK, Jeffrey P, Drewes G, Lee K, Huntly BJP, Kouzarides T Nature, 478(7370), 529, 2011 |